Print Page
<< Back

Mannatech Establishes Global Scientific Advisory Board to Advance Company’s Leadership of Science-Based Nutritional Technology

COPPELL, Texas--(BUSINESS WIRE)--Sep. 29, 2015-- Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5MSM (Mission 5 MillionSM) Foundation, the pioneer of glyconutrition and the global innovator of naturally sourced supplements based on Real Food Technology® solutions, announced the creation of a global Scientific Advisory Board. The Scientific Advisory Board will be comprised of third-party experts in the medical, science, health and wellness fields to further support and advance Mannatech’s continued commitment to providing groundbreaking, science-backed nutritional supplements to its worldwide customer base.

The Mannatech Scientific Advisory Board will begin organizing its membership of doctors, scientists and wellness experts immediately. Mannatech’s Global Wellness Director, Dr. Steve Nugent, will chair the advisory board. Mannatech staff, including Rolando Maddela, M.D., (MPH, CCRP) Mannatech’s Director of Clinical Research and Scientific Affairs and Tait Switzer, Vice President of Research and Development, will also support Dr. Nugent and the board members.

This global Scientific Advisory Board is part of CEO and President, Al Bala’s vision for ensuring that Mannatech delivers innovative nutritional technology and products that are supported by clinical trials and scientific validation. This safeguards that Mannatech products provide real results and improve the overall wellness of customers.

“Establishing the Scientific Advisory Board demonstrates Mannatech’s commitment to providing the highest quality, science-backed technologies that will delight our customers and that our sales Associates can use effectively to build their business around the world,” said Bala. “While there are many skincare and nutritional supplement companies, few have the technology that Mannatech has, which is backed by clinical studies, industry leading quality controls and patents. The Scientific Advisory Board, under the leadership of Dr. Nugent, will bring substantial and important expertise to our overall technology and product development process.”

Dr. Nugent brings to the Scientific Advisory Board more than 38 years of experience in the health and wellness industry. He has tested more than 6,000 dietary supplement products and has formulated more than 100 products. Dr. Nugent earned his doctorate from the University of the Rockies and is well respected worldwide as an authority on nutritional technology. He has been a source of knowledge and inspiration for Mannatech Associates who rely on his insights to help build strong and safe long-term businesses.

“It is a great honor for me to be asked to lead an independent board of experts to help continue Mannatech’s tradition of producing products validated by science,” said Dr. Nugent. “The Board’s mission is to provide objective, expert leadership to Mannatech and to ensure its technologies meet the highest standards. Mannatech’s foundation is built on science, and this board will ensure the company receives the most current feedback from scientists and wellness leaders from around the world.”

Mannatech’s Scientific Advisory Board will be specifically charged to review each new and existing product to ensure ingredients and formulations are up to pre-determined standards and are in-line with the latest, viable research. The board will also be called upon to make suggestions for new products. Additionally, board members will provide education and training to Associates on health and wellness topics.

To learn more about Mannatech, its products or business opportunities, please visit

About Mannatech

Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing childhood nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong Kong. For more information, visit

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Source: Mannatech, Incorporated

Mannatech, Incorporated
Kalyn Ballard, 972-471-7245